60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company is headquartered in Washington, District of Columbia. Show more
1025 CONNECTICUT AVENUE NW, WASHINGTON, DC, UNITED STATES, 20036, Washington, DC, 20036, USA
Market Cap
3.798M
52 Wk Range
$1.02 - $7.36
Previous Close
$1.13
Open
$1.13
Volume
51,475
Day Range
$1.04 - $1.16
Enterprise Value
12.67M
Cash
1.023M
Avg Qtr Burn
-2.232M
Insider Ownership
19.39%
Institutional Own.
17.11%
Qtr Updated
06/30/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Arakoda Details Malaria | Approved Quarterly sales | |
SJ733 Details Malaria | Phase 2b Initiation | |
Arakoda/Tafenoquine (TBA) (Antimalarial Agent) Details Chronic Babesiosis | Phase 2 Data readout | |
Arakoda (Tafenoquine) Details Babesiosis | Phase 2 Data readout | |
Tafenoquine Details COVID-19 | Failed Discontinued |
